Commercial Strategy and Market Access Sales Sheet
Fullscreen Mode
Commercial Strategy & Market Access
3 min read
Case Study: Optimizing Pricing Strategies for a Medical Device Product Family
Background A leading global medical device manufacturer faced a pricing strategy challenge and partnered with Veranex (formerly Boston Healthcare...
Recent Study Co-authored by Veranex Staff Highlights Cost-effectiveness of Home Non-invasive Ventilation in Patients with Chronic Obstructive Pulmonary Disease (COPD) in the United Kingdom
By developing a cost-effectiveness model and associated manuscript for home non-invasive ventilation in patients with persistent hypercapnia after an...
Veranex Supports Philips Healthcare with Writing Manuscript of Medicare Claims Study of Mobile Cardiac Monitoring
By leading the manuscript development, Veranex supported Philips Healthcare in publishing real-world evidence data supporting the use of Mobile...
Demonstrating Clinical Utility Using a Validated Methodology From the Market Research Toolkit
Veranex Director Lauren Fusfeld uses a case study to show how conjoint analysis can demonstrate to payers and health care providers the clinical...
Study by Veranex and Proteomics International Demonstrates Clinical Utility of Prognostic Test for Type 2 Diabetes Patients
By conducting a clinical utility study for Proteomics International’s PromarkerD (a blood-based test that predicts the risk of kidney disease/decline...
Published Health Economics Study Shows a High Disease Burden Associated with Stress/Mixed Urinary Incontinence to U.S. Payers
Veranex’s Commercial Strategy and Market Access team members, Manasi Datar, PhD, Li-Chen Pan, MPH, and Thomas F. Goss, PharmD, along with members...
Recent Study Co-Authored by Veranex to be Presented at ISPOR 2024
225,000 vitrectomy surgeries are performed annually in the U.S. A time-driven cost analysis conducted at a US academic hospital found the average...
Study Co-Authored by Veranex Found that Mobile Cardiac Outpatient Telemetry (MCOT) was Associated with Lower Readmissions and Healthcare Costs in Post-Stroke Monitored Patients, Compared to Implantabl
This study compares the health and economic outcomes of using mobile cardiac outpatient telemetry (MCOT) and implantable loop recorders (ILRs) for...
Study by Veranex and Thermo Fisher Highlights Payer Budget Impact of Novel Test for Kidney Transplant Rejection
By developing a U.S. payer budget impact model and associated manuscript for Thermo Fisher’s Molecular Microscope® MMDx®-Kidney (a microarray with...